Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Citicoline: pharmacological and clinical review, 2006 update.

Secades JJ, Lorenzo JL.

Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56. Review.

PMID:
17171187
2.

CDP-choline: pharmacological and clinical review.

Secades JJ, Frontera G.

Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54. Review.

PMID:
8709678
3.
4.

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.

PMID:
10669911
5.
6.

Efficacy of citicoline as an acute stroke treatment.

Clark WM.

Expert Opin Pharmacother. 2009 Apr;10(5):839-46. doi: 10.1517/17460440902835475 .

PMID:
19351232
7.

Citicoline: neuroprotective mechanisms in cerebral ischemia.

Adibhatla RM, Hatcher JF, Dempsey RJ.

J Neurochem. 2002 Jan;80(1):12-23. Review.

8.

"Brain-specific" nutrients: a memory cure?

McDaniel MA, Maier SF, Einstein GO.

Nutrition. 2003 Nov-Dec;19(11-12):957-75. Review.

PMID:
14624946
9.

Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury.

Xu F, Hongbin Han, Yan J, Chen H, He Q, Xu W, Zhu N, Zhang H, Zhou F, Lee K.

Drug Deliv. 2011 Sep-Oct;18(7):461-7. doi: 10.3109/10717544.2011.589084.

PMID:
21923252
10.

[Treatment of mild cognitive impairment: value of citicoline].

Abad-Santos F, Novalbos-Reina J, Gallego-Sandín S, García AG.

Rev Neurol. 2002 Oct 1-15;35(7):675-82. Review. Spanish.

11.

Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.

Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I.

Neurobiol Dis. 2005 Mar;18(2):336-45.

PMID:
15686962
12.

Membrane stabilizer: citicoline.

Zweifler RM.

Curr Med Res Opin. 2002;18 Suppl 2:s14-7. Review.

PMID:
12365823
13.

Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?

Parnetti L, Mignini F, Tomassoni D, Traini E, Amenta F.

J Neurol Sci. 2007 Jun 15;257(1-2):264-9. Epub 2007 Feb 28. Review.

PMID:
17331541
14.

Citicoline, use in cognitive decline: vascular and degenerative.

García-Cobos R, Frank-García A, Gutiérrez-Fernández M, Díez-Tejedor E.

J Neurol Sci. 2010 Dec 15;299(1-2):188-92. doi: 10.1016/j.jns.2010.08.027. Epub 2010 Sep 27. Review.

PMID:
20875651
17.

The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.

Gareri P, Castagna A, Cotroneo AM, Putignano S, De Sarro G, Bruni AC.

Clin Interv Aging. 2015 Sep 3;10:1421-9. doi: 10.2147/CIA.S87886. eCollection 2015. Review. Erratum in: Clin Interv Aging. 2015;10:1625.

18.
19.

Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.

Alonso de Leciñana M, Gutiérrez M, Roda JM, Carceller F, Díez-Tejedor E.

J Neurol Sci. 2006 Sep 25;247(2):121-9. Epub 2006 Jun 22.

PMID:
16797595
20.

A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.

Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA.

Neurology. 1997 Sep;49(3):671-8.

PMID:
9305321

Supplemental Content

Support Center